Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant

OBJECTIVES: The emergence of a SARS‐CoV‐2 variant with a point mutation in the spike (S) protein, D614G, has taken precedence over the original Wuhan isolate by May 2020. With an increased infection and transmission rate, it is imperative to determine whether antibodies induced against the D614 isol...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Cheryl Yi‐Pin, Amrun, Siti Naqiah, Chee, Rhonda Sin‐Ling, Goh, Yun Shan, Mak, Tze‐Minn, Octavia, Sophie, Yeo, Nicholas Kim‐Wah, Chang, Zi Wei, Tay, Matthew Zirui, Torres‐Ruesta, Anthony, Carissimo, Guillaume, Poh, Chek Meng, Fong, Siew‐Wai, Bei, Wang, Lee, Sandy, Young, Barnaby Edward, Tan, Seow‐Yen, Leo, Yee‐Sin, Lye, David C, Lin, Raymond TP, Maurer‐Stroh, Sebastien, Lee, Bernett, Wang, Cheng‐I, Renia, Laurent, Ng, Lisa FP
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899292/
https://www.ncbi.nlm.nih.gov/pubmed/33628442
http://dx.doi.org/10.1002/cti2.1241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899292/
https://www.ncbi.nlm.nih.gov/pubmed/33628442
http://dx.doi.org/10.1002/cti2.1241

Ejemplares similares